Brigham and Women's Hospital — Biomedical Watch V2

Essais liés23clinical trials

VilleBostonlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05617014

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
Nerandomilast	Myopathies	Phase 3	NCT07789015	VERANDA™-IIM — A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies	NOT_YET_RECRUITING
CABA-201	Lupus	Phase 1/2	NCT06121297	RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus	RECRUITING
Emtricitabine and tenofovir disoproxil fumarate combination	Alzheimer	Phase 1	NCT07795307	Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease	NOT_YET_RECRUITING
Donanemab	Alzheimer	Phase 3	NCT04437511	A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)	ACTIVE_NOT_RECRUITING
Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis	SEP	À vérifier	NCT03138525	Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis	COMPLETED
PF-07799544	Cancer	Phase 1	NCT05538130	A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors	RECRUITING
CORAL — Cocoa Extract for Migraine Trial	Migraine	Non applicable	NCT06808230	CORAL — Cocoa Extract for Migraine Trial	RECRUITING
Descartes-08	Myopathies	Phase 2	NCT07391605	Descartes-08 in Autoantibody Myositis	RECRUITING
Neuraceq	Alzheimer	À vérifier	NCT05617014	ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4	ENROLLING_BY_INVITATION
Study Subjects	Épilepsie	Non applicable	NCT06135285	A Device to Prevent Sudden Unexpected Death in Epilepsy: Detecting Peri-Ictal Body Position	NOT_YET_RECRUITING
Acoramidis	Alzheimer	Phase 3	NCT06563895	Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	RECRUITING
Mycophenolate Mofetil	Myasthénie	À vérifier	NCT03490539	PROMISE-MG — Disease-Modifying Treatments for Myasthenia Gravis	COMPLETED
Litifilimab	Lupus	Phase 2/3	NCT05531565	AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	ACTIVE_NOT_RECRUITING
XEN1101	Épilepsie	Phase 3	NCT05718817	X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy	ENROLLING_BY_INVITATION
CT1812	Alzheimer	Phase 2	NCT05531656	A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	ACTIVE_NOT_RECRUITING
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	Alzheimer	À vérifier	NCT01078636	ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	COMPLETED
Robotic-Assisted Surgery	Myasthénie	Non applicable	NCT05150210	SP Thoracic IDE Study	ACTIVE_NOT_RECRUITING
Ocrelizumab	SEP	À vérifier	NCT05131984	Ocrelizumab Access by Socio-Economic Status	COMPLETED
Bevacizumab	Cancer	Phase 2	NCT00861705	Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	COMPLETED
Foralumab	SEP	Phase 2	NCT06292923	A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients	ACTIVE_NOT_RECRUITING
Foralumab TZLS-401 100 µg	SEP	Phase 2	NCT06890923	TILS-022 — Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis	RECRUITING
Foralumab TZLS-401 50 µg	SEP	À vérifier	NCT06802328	Intermediate-Size Patient Population Expanded Access: Foralumab in Non-Active Secondary Progressive MS Patients	AVAILABLE
A Study of Brain Aging in Vietnam War Veterans	Alzheimer	À vérifier	NCT01687153	A Study of Brain Aging in Vietnam War Veterans	COMPLETED